Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Senokot is a prominent consumer healthcare brand specializing in natural vegetable laxative products designed to treat occasional constipation. The brand's formulations are centered around sennosides, natural compounds derived from the senna plant that stimulate the bowel muscles to facilitate movement. Currently managed by Avrio Health, a subsidiary of Purdue Pharma, Senokot offers a diverse product line including traditional tablets, liquid formulations, and dietary supplement gummies. It is widely recognized for its Senokot-S variant, which combines a stimulant laxative with a stool softener for more comprehensive relief. The brand has maintained a significant presence in the over-the-counter gastrointestinal market for over six decades. Senokot products are frequently recommended by healthcare professionals for both general constipation and specialized needs such as opioid-induced bowel dysfunction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Senokot.